The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Tenet Healthcare's revenues will increase 2.7% and EPS will decrease -19.0%.
The average estimate for revenue is $2.48 billion. On the bottom line, the average EPS estimate is $0.68.
Last quarter, Tenet Healthcare booked revenue of $2.43 billion. GAAP reported sales were 6.0% higher than the prior-year quarter's $2.29 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.32. GAAP EPS of $0.37 for Q3 were much higher than the prior-year quarter's $0.05 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 41.2%, 150 basis points better than the prior-year quarter. Operating margin was 6.6%, 280 basis points better than the prior-year quarter. Net margin was 1.7%, 120 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $9.65 billion. The average EPS estimate is $1.88.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 362 members out of 431 rating the stock outperform, and 69 members rating it underperform. Among 97 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 85 give Tenet Healthcare a green thumbs-up, and 12 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Tenet Healthcare is outperform, with an average price target of $24.97.
Is Tenet Healthcare the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Tenet Healthcare to My Watchlist.